{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:37:57Z","timestamp":1791045477152,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jsat.2017.12.003","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T18:53:04Z","timestamp":1513104784000},"page":"17-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Associations between pharmacotherapy for opioid dependence and clinical and criminal justice outcomes among adults with co-occurring serious mental illness"],"prefix":"10.1016","volume":"86","author":[{"given":"Allison G.","family":"Robertson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele M.","family":"Easter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Ju","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda K.","family":"Frisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey W.","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin S.","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2017.12.003_bb0005","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1037\/0003-066X.46.10.1036","article-title":"Co-occurring disorders among mentally ill jail detainees: Implications for public policy","volume":"46","author":"Abram","year":"1991","journal-title":"The American Psychologist"},{"key":"10.1016\/j.jsat.2017.12.003_bb0010","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1176\/appi.ajp.160.5.1007","article-title":"Comorbidity of severe psychiatric disorders and substance use disorders among women in jail","volume":"160","author":"Abram","year":"2003","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jsat.2017.12.003_bb0015","doi-asserted-by":"crossref","DOI":"10.1007\/s10597-017-0113-z","article-title":"Reincarceration risk among men with mental illnesses leaving prison: A risk environment analysis","author":"Barrenger","year":"2017","journal-title":"Community Mental Health Journal"},{"issue":"9","key":"10.1016\/j.jsat.2017.12.003_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11090","article-title":"Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation","volume":"11","author":"Connock","year":"2007","journal-title":"Health Technology Assessment"},{"key":"10.1016\/j.jsat.2017.12.003_bb0025","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reductions in the comparison of a treatment to a non-randomized control group","volume":"17","author":"D'Agostino","year":"1998","journal-title":"Statistics in Medicine"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2017.12.003_bb0030","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2012.12.010","article-title":"Patient characteristics associated with buprenorphine\/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study","volume":"131","author":"Dreifuss","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.jsat.2017.12.003_bb0035","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jsat.2011.04.003","article-title":"Preliminary evaluation of extended-release naltrexone in Michigan and Missouri drug courts","volume":"41","author":"Finigan","year":"2011","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2017.12.003_bb0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/08897077.2011.611460","article-title":"Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): Availability, barriers, and intentions","volume":"33","author":"Friedmann","year":"2012","journal-title":"Substance Abuse"},{"issue":"2","key":"10.1016\/j.jsat.2017.12.003_bb0045","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.pnpbp.2005.10.007","article-title":"Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study","volume":"30","author":"Gerra","year":"2006","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.jsat.2017.12.003_bb0050","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1176\/appi.ajp.161.4.692","article-title":"Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia","volume":"161","author":"Gilmer","year":"2004","journal-title":"The American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.jsat.2017.12.003_bb0055","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/08897077.2011.616816","article-title":"Opioid agonist maintenance for probationers: Patient-level predictors of treatment retention, drug use, and crime","volume":"33","author":"Gryczynski","year":"2012","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2017.12.003_bb0060","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2165\/00003495-200262050-00003","article-title":"Substance misuse in patients with schizophrenia: Epidemiology and management","volume":"62","author":"Kavanagh","year":"2002","journal-title":"Drugs"},{"issue":"24","key":"10.1016\/j.jsat.2017.12.003_bb0065","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1056\/NEJMsa043266","article-title":"Prevalence and treatment of mental disorders, 1990 to 2003","volume":"352","author":"Kessler","year":"2005","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2017.12.003_bb0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/ADM.0b013e3181d41ddb","article-title":"Adoption and implementation of medications in addiction treatment programs","volume":"5","author":"Knudsen","year":"2011","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2017.12.003_bb0075","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1080\/10550881003684798","article-title":"Pharmacotherapy in the treatment of addiction: methadone","volume":"29","author":"Kreek","year":"2010","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2017.12.003_bb0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-244X-10-9","article-title":"Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study","volume":"10","author":"Lagerberg","year":"2010","journal-title":"BMC Psychiatry"},{"issue":"13","key":"10.1016\/j.jsat.2017.12.003_bb0085","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJMoa1505409","article-title":"Extended-release naltrexone to prevent opioid relapse in criminal justice offenders","volume":"374","author":"Lee","year":"2016","journal-title":"The New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2017.12.003_bb0090","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/08897077.2011.620475","article-title":"Buprenorphine-naloxone maintenance following release from jail","volume":"33","author":"Lee","year":"2012","journal-title":"Substance Abuse"},{"issue":"1","key":"10.1016\/j.jsat.2017.12.003_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08897077.2011.616797","article-title":"Opioid pharmacotherapy in criminal justice settings: Now is the time","volume":"33","author":"Lee","year":"2012","journal-title":"Substance Abuse"},{"issue":"1","key":"10.1016\/j.jsat.2017.12.003_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"issue":"2","key":"10.1016\/j.jsat.2017.12.003_bb0105","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jad.2013.06.054","article-title":"The long-term outcomes of heroin dependent-treatment-resistant patients with bipolar 1 comorbidity after admission to enhanced methadone maintenance","volume":"151","author":"Maremmani","year":"2013","journal-title":"Journal of Affective Disorders"},{"issue":"3","key":"10.1016\/j.jsat.2017.12.003_bb0110","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000130417","article-title":"Long-term outcomes of treatment-resistant heroin addicts with and without DSM-IV axis I psychiatric comorbidity (dual diagnosis)","volume":"14","author":"Maremmani","year":"2008","journal-title":"European Addiction Research"},{"key":"10.1016\/j.jsat.2017.12.003_bb0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0920-9964(02)00523-6","article-title":"Drug and alcohol use among patients with schizophrenia and related psychoses: Levels and consequences","volume":"67","author":"Margolese","year":"2004","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jsat.2017.12.003_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/h0093963","article-title":"Stopping the revolving door: A meta-analysis on the effectiveness of interventions for criminally involved individuals with major mental disorders","volume":"36","author":"Martin","year":"2011","journal-title":"Law and Human Behavior"},{"key":"10.1016\/j.jsat.2017.12.003_bb0125","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"3","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2017.12.003_bb0130","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1016\/j.jsat.2017.12.003_bb0135","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jsat.2012.10.004","article-title":"Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes","volume":"44","author":"Matusow","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2017.12.003_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001333.pub3","article-title":"Oral naltrexone maintenance treatment for opioid dependence","volume":"4","author":"Minozzi","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2017.12.003_bb0145","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/070674370304800104","article-title":"Clinical aspects of substance abuse in persons with schizophrenia","volume":"48","author":"Negrete","year":"2003","journal-title":"Canadian Journal of Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2017.12.003_bb0150","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.drugalcdep.2009.06.015","article-title":"Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a nationwide survey","volume":"105","author":"Nunn","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2017.12.003_bb0155","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1098\/rstb.2008.0105","article-title":"Evidence-based treatments of addiction","volume":"363","author":"O'Brien","year":"2008","journal-title":"Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences"},{"key":"10.1016\/j.jsat.2017.12.003_bb0160","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1600-0447.2011.01700.x","article-title":"Involuntary hospitalization of first-episode psychosis with substance abuse during a 2-year follow-up","volume":"124","author":"Opsal","year":"2011","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3","key":"10.1016\/j.jsat.2017.12.003_bb0165","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/jurban\/jti072","article-title":"Attitudes and practices regarding the use of methadone in US state and federal prisons","volume":"82","author":"Rich","year":"2005","journal-title":"Journal of Urban Health"},{"key":"10.1016\/j.jsat.2017.12.003_bb0170","series-title":"\u201cAvailability without accessibility? State Medicaid coverage and authorization requirements for opioid dependence medications.\u201d Advancing access to addiction medications: Implications for opioid addiction treatment","author":"Rinaldo","year":"2013"},{"issue":"9","key":"10.1016\/j.jsat.2017.12.003_bb0175","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1176\/appi.ps.201300286","article-title":"The effects of brief incarcerations before jail diversion on program participants' health and reoffending outcomes","volume":"65","author":"Robertson","year":"2014","journal-title":"Psychiatric Services"},{"issue":"10","key":"10.1016\/j.jsat.2017.12.003_bb0180","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1176\/appi.ps.201400247","article-title":"Effects of early and consistent treatment participation and medication adherence on arrest and incarceration costs for persons with serious mental illness","volume":"65","author":"Robertson","year":"2014","journal-title":"Psychiatric Services"},{"issue":"7","key":"10.1016\/j.jsat.2017.12.003_bb0185","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1176\/appi.ps.201300044","article-title":"Patterns of justice involvement among adults with schizophrenia and bipolar disorder: Key risk factors","volume":"65","author":"Robertson","year":"2014","journal-title":"Psychiatric Services"},{"issue":"12","key":"10.1016\/j.jsat.2017.12.003_bb0190","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.3109\/10826081003791932","article-title":"VEdeTTE study group. Effectiveness of therapies for heroin addiction in retaining patients in treatment: Results from the VEdeTTE study","volume":"45","author":"Salamina","year":"2010","journal-title":"Substance Use & Misuse"},{"key":"10.1016\/j.jsat.2017.12.003_bb0195","doi-asserted-by":"crossref","first-page":"413","DOI":"10.15288\/jsad.2012.73.413","article-title":"Advancing recovery: Implementing evidence-based treatment for substance use disorders at the systems level","volume":"73","author":"Schmidt","year":"2012","journal-title":"Journal of Studies on Alcohol and Drugs"},{"key":"10.1016\/j.jsat.2017.12.003_bb0200","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s10979-008-9140-1","article-title":"Social networks and social control of probationers with co-occurring mental and substance abuse problems","volume":"33","author":"Skeem","year":"2008","journal-title":"Law and Human Behavior"},{"key":"10.1016\/j.jsat.2017.12.003_bb0205","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s10979-010-9223-7","article-title":"Correctional policy for offenders with mental illness: Creating a new paradigm for recidivism reduction","volume":"35","author":"Skeem","year":"2011","journal-title":"Law and Human Behavior"},{"key":"10.1016\/j.jsat.2017.12.003_bb0210","author":"State of Connecticut Department of Social Services"},{"key":"10.1016\/j.jsat.2017.12.003_bb0215","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1176\/ps.2009.60.6.761","article-title":"Prevalence of serious mental illness among jail inmates","volume":"60","author":"Steadman","year":"2009","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.jsat.2017.12.003_bb0220","series-title":"Mental Health, United States, 2010. HHS Publication No. (SMA) 12-4681","author":"Substance Abuse and Mental Health Services Administration","year":"2012"},{"key":"10.1016\/j.jsat.2017.12.003_bb0225","series-title":"Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-48, HHS Publication No. (SMA) 14-4863","author":"Substance Abuse and Mental Health Services Administration","year":"2014"},{"key":"10.1016\/j.jsat.2017.12.003_bb0230","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1176\/appi.ps.52.6.805","article-title":"Using drug claims data to assess the relationship of medication adherence with hospitalization and costs","volume":"52","author":"Svarstad","year":"2001","journal-title":"Psychiatric Services"},{"issue":"17","key":"10.1016\/j.jsat.2017.12.003_bb0235","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/jama.2016.12434","article-title":"Mental illness, release from prison, and social context","volume":"316","author":"Swanson","year":"2016","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jsat.2017.12.003_bb0240","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1176\/appi.ps.002212012","article-title":"Costs of criminal justice involvement among persons with severe mental illness in Connecticut","volume":"64","author":"Swanson","year":"2013","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.jsat.2017.12.003_bb0245","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1176\/ps.2010.61.10.976","article-title":"Assessing outcomes for consumers in New York's assisted outpatient treatment program","volume":"61","author":"Swartz","year":"2010","journal-title":"Psychiatric Services"},{"issue":"2","key":"10.1016\/j.jsat.2017.12.003_bb0250","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2105\/AJPH.84.2.290","article-title":"Psychiatric and substance abuse disorders among urban jail detainees","volume":"84","author":"Teplin","year":"1994","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.jsat.2017.12.003_bb0255","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/archpsyc.1996.01830060047007","article-title":"Prevalence of psychiatric disorders among female jail detainees","volume":"53","author":"Teplin","year":"1996","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jsat.2017.12.003_bb0260","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1192\/bjp.bp.108.057471","article-title":"Impact of persistent substance misuse on 1-year outcome in first-episode psychosis","volume":"195","author":"Turkington","year":"2009","journal-title":"The British Journal of Psychiatry"},{"issue":"6","key":"10.1016\/j.jsat.2017.12.003_bb0265","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.genhosppsych.2011.06.004","article-title":"Factors affecting psychiatric inpatient hospitalization from a psychiatric emergency service","volume":"33","author":"Unick","year":"2011","journal-title":"General Hospital Psychiatry"},{"key":"10.1016\/j.jsat.2017.12.003_bb0270","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/00005650-200208000-00002","article-title":"Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission","volume":"40","author":"Valenstein","year":"2002","journal-title":"Medical Care"},{"issue":"22","key":"10.1016\/j.jsat.2017.12.003_bb0275","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies\u2014Tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"The New England Journal of Medicine"},{"issue":"12","key":"10.1016\/j.jsat.2017.12.003_bb0280","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1176\/appi.ajp.158.12.2027","article-title":"Ethnic disparities in unmet need for alcoholism, drug abuse, and mental health care","volume":"158","author":"Wells","year":"2001","journal-title":"The American Journal of Psychiatry"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547217304245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547217304245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:46:37Z","timestamp":1760039197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547217304245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":56,"alternative-id":["S0740547217304245"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2017.12.003","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between pharmacotherapy for opioid dependence and clinical and criminal justice outcomes among adults with co-occurring serious mental illness","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2017.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}